High-intensity Laser Therapy Improves Pain, Health Status and Quality of Life in Women With Fibromyalgia
1 other identifier
interventional
52
1 country
1
Brief Summary
This study will be conducted to investigate High-intensity laser therapy improves pain, health status and quality of life in women with fibromyalgia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 7, 2023
CompletedFirst Posted
Study publicly available on registry
June 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedMarch 19, 2024
March 1, 2024
4 months
June 7, 2023
March 16, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Revised Fibromyalgia Impact Questionnaire (FIQR)
assesses the overall severity of FM and health status based on participant ratings. It encompasses three key domains similar to the FIQ (function, overall impact, and symptoms), with additional inquiries regarding memory, tenderness, balance, and environmental sensitivity
up to 6 weeks
Visual Analog Scale (VAS)
10 cm, where patients rated their pain on a scale from 0 ("no pain") to 10 ("extremely severe pain ") over the past 3 days
up to 6 weeks
pressure algometer
This tool comprises a circular rubber tip (1 cm2) and a pressure gauge for displaying readings in kilograms. Given the rubber tip's 1 cm² area, measurements were reported in kilograms per square centimeter (kg/cm2). The algometer has a measurement range from 0 to 10 kg, with increments of 0.1 kg. The instrument was pressed against the skin's surface at a right angle, and the force exerted was registered on a manometer.
up to 6 weeks
Study Arms (2)
traditional exercise therapy only
EXPERIMENTALThis 50-minute program included a 10-minute warm-up phase (treadmill walking at a comfortable speed), 30 minutes of stretching exercises for (glutei, paraspinal muscles, hamstring, pectoralis, scalenus, intercostal muscles, and trapezius), and a 10-minute cool-down involving self-stretching and respiratory exercises.
HILT alongside traditional exercise therapy,
EXPERIMENTALpulsed Nd: YAG laser device (HIRO 3.0; ASA Laser, Arcugnano, Italy). This equipment delivers pulsed laser light at a wavelength of 1,064 nm, with a very high peak power of 3 kW and energy density ranging from 360 to 1,780 mJ/cm2.
Interventions
50-minute program included a 10-minute warm-up phase (treadmill walking at a comfortable speed), 30 minutes of stretching exercises for (glutei, paraspinal muscles, hamstring, pectoralis, scalenus, intercostal muscles, and trapezius), and a 10-minute cool-down involving self-stretching and respiratory exercises
YAG laser device (HIRO 3.0; ASA Laser, Arcugnano, Italy). This equipment delivers pulsed laser light at a wavelength of 1,064 nm, with a very high peak power of 3 kW and energy density ranging from 360 to 1,780 mJ/cm2. It operates with short pulse durations between 120 and 150 μs, at low frequencies of 10 to 40 Hz, and has a duty cycle of about 0.1%.
Eligibility Criteria
You may qualify if:
- WPI ≥ 7/19 pain sites and SSS ≥ 5/12 or WPI between \> 3-6/19 and SSS \> 9/12
- symptoms have been present at a similar level for at least 3 months
- the patient does not have another disorder that would otherwise sufficiently explain the pain
- generalized pain, defined as pain in at least four of five regions, is present
You may not qualify if:
- uncontrolled diabetes
- known history of cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kerolous Ishak Shehata Kelini
Giza, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
June 7, 2023
First Posted
June 15, 2023
Study Start
January 29, 2023
Primary Completion
June 1, 2023
Study Completion
September 1, 2023
Last Updated
March 19, 2024
Record last verified: 2024-03